Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2658)
All Articles published online
|
Dec 15, 2003 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wiercinska-Drapalo A, Jaroszewicz J, Flisiak R, Prokopowicz D. Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 as biomarkers of ulcerative colitis activity. World J Gastroenterol 2003; 9(12): 2843-2845 [PMID: 14669348 DOI: 10.3748/wjg.v9.i12.2843] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i12/2843.htm |
| Number | Citing Articles |
| 1 |
Elee Shimshoni, Doron Yablecovitch, Liran Baram, Iris Dotan, Irit Sagi. ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation. Gut 2015; 64(3): 367 doi: 10.1136/gutjnl-2014-308048
|
| 2 |
László Herszényi, Loránd Barabás, István Hritz, Gábor István, Zsolt Tulassay. Impact of proteolytic enzymes in colorectal cancer development and progression. World Journal of Gastroenterology 2014; 20(37): 13246-13257 doi: 10.3748/wjg.v20.i37.13246
|
| 3 |
Wei Chen, Wei Da, Chen Li, Huining Fan, Rui Liang, Junqing Yuan, Xiaoqing Huang, Renzhi Yang, Jing Zhang, Jinshui Zhu. Network pharmacology-based identification of the protective mechanisms of taraxasterol in experimental colitis. International Immunopharmacology 2019; 71: 259 doi: 10.1016/j.intimp.2019.03.042
|
| 4 |
AR Al‐Azri, RJ Gibson, DMK Keefe, RM Logan. Matrix metalloproteinases: do they play a role in mucosal pathology of the oral cavity?. Oral Diseases 2013; 19(4): 347 doi: 10.1111/odi.12023
|
| 5 |
Aleksandra Czajkowska, Katarzyna Guzinska-Ustymowicz, Anna Pryczynicz, Dariusz Lebensztejn, Urszula Daniluk. Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis?. Journal of Clinical Medicine 2022; 11(9): 2655 doi: 10.3390/jcm11092655
|
| 6 |
Mirko Di Ruscio, Filippo Vernia, Antonio Ciccone, Giuseppe Frieri, Giovanni Latella. Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?. Inflammatory Bowel Diseases 2018; 24(1): 78 doi: 10.1093/ibd/izx011
|
| 7 |
Zhaoji Pan, Hao Lin, Yanyan Fu, Fanpeng Zeng, Feng Gu, Guoping Niu, Jian Fang, Bing Gu. Identification of gene signatures associated with ulcerative colitis and the association with immune infiltrates in colon cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1086898
|
| 8 |
Sridevi Devaraj, Grant O’Keefe, Ishwarlal Jialal. Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker. The Journal of Clinical Endocrinology & Metabolism 2005; 90(8): 4549 doi: 10.1210/jc.2005-0069
|
| 9 |
Laura Mäkitalo, Hanne Rintamäki, Taina Tervahartiala, Timo Sorsa, Kaija-Leena Kolho. Serum MMPs 7–9 and their inhibitors during glucocorticoid and anti-TNF-α therapy in pediatric inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2012; 47(7): 785 doi: 10.3109/00365521.2012.677954
|
| 10 |
Vincenza De Gregorio, Giorgia Imparato, Francesco Urciuolo, Paolo A. Netti. Micro-patterned endogenous stroma equivalent induces polarized crypt-villus architecture of human small intestinal epithelium. Acta Biomaterialia 2018; 81: 43 doi: 10.1016/j.actbio.2018.09.061
|
| 11 |
Alicja Wiercinska-Drapalo, Robert Flisiak, Jerzy Jaroszewicz, Danuta Prokopowicz. Plasma interleukin-18 reflects severity of ulcerative colitis. World Journal of Gastroenterology 2005; 11(4): 605-608 doi: 10.3748/wjg.v11.i4.605
|
| 12 |
Yoshiki Kawamura, Ken Sugata, Hidetaka Nakai, Yoshizo Asano, Masahiro Ohashi, Tomochika Kato, Naoko Nishimura, Takao Ozaki, Akiko Yui, Koki Taniguchi, Tetsushi Yoshikawa. Correlation between serum matrix metalloproteinase and antigenemia levels in patients infected with rotavirus. Journal of Medical Virology 2012; 84(6): 986 doi: 10.1002/jmv.23296
|
| 13 |
Anje A. te Velde, Floor de Kort, Ellen Sterrenburg, Inge Pronk, Fiebo J.W. ten Kate, Daniel W. Hommes, Sander J.H. van Deventer. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflammatory Bowel Diseases 2007; 13(3): 325 doi: 10.1002/ibd.20079
|
| 14 |
Ying-De Wang, Xiao-Yan Tan, Ke Zhang. Correlation of Plasma MMP-1 and TIMP-1 Levels and the Colonic Mucosa Expressions in Patients with Ulcerative Colitis. Mediators of Inflammation 2009; 2009: 1 doi: 10.1155/2009/275072
|
| 15 |
Anupama Ravi, Pallavi Garg, Shanthi V. Sitaraman. Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane?. Inflammatory Bowel Diseases 2007; 13(1): 97 doi: 10.1002/ibd.20011
|
| 16 |
László Herszényi, István Hritz, Gábor Lakatos, Mária Varga, Zsolt Tulassay. The Behavior of Matrix Metalloproteinases and Their Inhibitors in Colorectal Cancer. International Journal of Molecular Sciences 2012; 13(12): 13240 doi: 10.3390/ijms131013240
|
| 17 |
Federico Carbone, Giorgia Bodini, Matteo Brunacci, Aldo Bonaventura, Alessandra Vecchiè, Luca Liberale, Mattia Crespi, Isabella Baldissarro, Franco Dallegri, Vincenzo Savarino, Fabrizio Montecucco, Edoardo G. Giannini. Reduction in TIMP‐2 serum levels predicts remission of inflammatory bowel diseases. European Journal of Clinical Investigation 2018; 48(10) doi: 10.1111/eci.13002
|
| 18 |
Ying-De Wang, Pei-Yun Yan. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis. World Journal of Gastroenterology 2006; 12(37): 6050-6053 doi: 10.3748/wjg.v12.i37.6050
|
| 19 |
Noemi Eiro, Eva Barreiro-Alonso, Maria Fraile, Luis O. González, Antonio Altadill, Francisco J. Vizoso. Expression of MMP-2, MMP-7, MMP-9, and TIMP-1 by Inflamed Mucosa in the Initial Diagnosis of Ulcerative Colitis as a Response Marker for Conventional Medical Treatment. Pathobiology 2023; 90(2): 81 doi: 10.1159/000524978
|
| 20 |
Bashir M. Mohamed, Conleth Feighery, Jacinta Kelly, Christian Coates, Una O’Shea, Louise Barnes, Mohamed Abuzakouk. Increased Protein Expression of Matrix Metalloproteinases -1, -3, and -9 and TIMP-1 in Patients with Gluten-Sensitive Enteropathy. Digestive Diseases and Sciences 2006; 51(10): 1862 doi: 10.1007/s10620-005-9038-4
|
| 21 |
Carolijn Smids, Carmen S Horjus Talabur Horje, Stefan Nierkens, Julia Drylewicz, Marcel J M Groenen, Peter J Wahab, Ellen G van Lochem. Candidate Serum Markers in Early Crohn’s Disease: Predictors of Disease Course. Journal of Crohn's and Colitis 2017; 11(9): 1090 doi: 10.1093/ecco-jcc/jjx049
|
| 22 |
Barbara Sosna, David Aebisher, Angelika Myśliwiec, Klaudia Dynarowicz, Dorota Bartusik-Aebisher, Piotr Oleś, Grzegorz Cieślar, Aleksandra Kawczyk-Krupka. Selected Cytokines and Metalloproteinases in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2023; 25(1): 202 doi: 10.3390/ijms25010202
|
| 23 |
Yuji Naito, Toshikazu Yoshikawa. Role of matrix metalloproteinases in inflammatory bowel disease. Molecular Aspects of Medicine 2005; 26(4-5): 379 doi: 10.1016/j.mam.2005.07.009
|
| 24 |
Malgorzata Matusiewicz, Katarzyna Neubauer, Magdalena Mierzchala-Pasierb, Andrzej Gamian, Malgorzata Krzystek-Korpacka. Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases. Disease Markers 2014; 2014: 1 doi: 10.1155/2014/643645
|
| 25 |
Anna Solberg, Lena Holmdahl, Peter Falk, Ingrid Palmgren, Marie-Louise Ivarsson. A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis. International Journal of Colorectal Disease 2008; 23(6): 611 doi: 10.1007/s00384-008-0452-x
|
| 26 |
Magali de Bruyn, Jennifer Vandooren, Estefania Ugarte-Berzal, Ingrid Arijs, Séverine Vermeire, Ghislain Opdenakker. The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases. Critical Reviews in Biochemistry and Molecular Biology 2016; 51(5): 295 doi: 10.1080/10409238.2016.1199535
|
| 27 |
Jacek Kurzepa, Agnieszka Mdro, Grażyna Czechowska, Joanna Kurzepa, Krzysztof Celiński, Weronika Kazmierak, Maria Slstrokomka. Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases. Hepatobiliary & Pancreatic Diseases International 2014; 13(6): 570 doi: 10.1016/S1499-3872(14)60261-7
|
| 28 |
Clinical Significance of CD147 in Children with Inflammatory Bowel Disease. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/7647181
|
| 29 |
Vincent Mariaule, Aicha Kriaa, Souha Soussou, Soufien Rhimi, Houda Boudaya, Juan Hernandez, Emmanuelle Maguin, Adam Lesner, Moez Rhimi. Digestive Inflammation: Role of Proteolytic Dysregulation. International Journal of Molecular Sciences 2021; 22(6): 2817 doi: 10.3390/ijms22062817
|
| 30 |
Martin Marônek, Irene Marafini, Roman Gardlík, René Link, Edoardo Troncone, Giovanni Monteleone. Metalloproteinases in Inflammatory Bowel Diseases. Journal of Inflammation Research 2021; : 1029 doi: 10.2147/JIR.S288280
|
| 31 |
Andreas N Kapsoritakis, Anastasia I Kapsoritaki, Ioanna P Davidi, Vasilios D Lotis, Anastasios C Manolakis, Petros I Mylonis, Aikaterini T Theodoridou, Anastasios E Germenis, Spyros P Potamianos. Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease. BMC Gastroenterology 2008; 8(1) doi: 10.1186/1471-230X-8-55
|